Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Chinese Patent Office
Federal Trade Commission
Farmers Insurance

Generated: December 12, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Calcium Gluceptate patents expire, and what generic alternatives are available?

Calcium Gluceptate is a drug marketed by Abbott, Abraxis Pharm, and Lilly. and is included in four NDAs.

The generic ingredient in CALCIUM GLUCEPTATE is calcium gluceptate. There are two hundred and seventy drug master file entries for this compound. Additional details are available on the calcium gluceptate profile page.


Drug patent expirations by year for CALCIUM GLUCEPTATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AbbottCALCIUM GLUCEPTATEcalcium gluceptateINJECTABLE;INJECTION080001-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LillyCALCIUM GLUCEPTATEcalcium gluceptateINJECTABLE;INJECTION006470-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbottCALCIUM GLUCEPTATEcalcium gluceptateINJECTABLE;INJECTION083159-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Abraxis PharmCALCIUM GLUCEPTATEcalcium gluceptateINJECTABLE;INJECTION089373-001Apr 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Express Scripts
Harvard Business School
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: